Acta Medica Okayama volume73 issue6
2019-12 発行

Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs

Takahara, Yasuhiro Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Nishida, Keiichiro Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kakenhi
Nakashima, Hirotaka Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Ochi, Nobuaki Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Uchida, Yoichiro Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Kato, Hisayoshi Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Itani, Satoru Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Nakamura, Makoto Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Iwasaki, Yuichi Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Tsujimura, Yoshitaka Department of Orthopedic Surgery, Nippon Kokan Fukuyama Hospital
Publication Date
2019-12
Abstract
High tibial osteotomy (HTO) procedure is generally contraindicated in rheumatoid arthritis (RA) patients because synovial inflammation may exacerbate joint damage post-surgery. The natural course of joint destruction in RA changed dramatically with new treatment strategies and the introduction of biologic disease-modifying anti-rheumatic drugs (bDMARDs). We report the cases of two RA patients who underwent HTO and whose disease activities were well controlled by bDMARDs. Despite their short follow-up periods, they showed acceptable objective and subjective clinical results. We believe that the combination of bDMARDs and HTO can be indicated for selected RA patients before total knee arthroplasty.
Document Type
Case Report
Keywords
high tibial osteotomy
rheumatoid arthritis
biologic DMARD
knee surgery
Link to PubMed
Thumnail 73_6_537.pdf 9.44 MB